A detailed history of Concentric Capital Strategies, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 60,564 shares of CYTK stock, worth $3.14 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
60,564
Previous 40,207 50.63%
Holding current value
$3.14 Million
Previous $2.82 Million 16.43%
% of portfolio
0.17%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $974,286 - $1.53 Million
20,357 Added 50.63%
60,564 $3.28 Million
Q1 2024

May 14, 2024

BUY
$63.75 - $108.06 $2.56 Million - $4.34 Million
40,207 New
40,207 $2.82 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.88B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.